Xvivo Perfusion
470
SEK
+2.62 %
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Less than 1K followers
+2.62%
-3.89%
-3.98%
+1.73%
-8.02%
+60.41%
+85.4%
+147.37%
+2,373.68%
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
14.8B SEK
Turnover
52.03M SEK
Revenue
822.42M
EBIT %
10.74 %
P/E
85.92
Dividend yield-%
-
Financial calendar
24.4
2025
Interim report Q1'25
25.4
2025
General meeting '25
11.7
2025
Interim report Q2'25
ShowingAll content types
XVIVO, Audiocast with teleconference, Q4'24
Year-end report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools